Merri Moken has practiced intellectual property law for nearly a decade, with a particular focus on patent litigation pertaining to the chemical, pharmaceutical, mechanical and electrical arts. During this time she has practiced before federal district and appellate courts, and the International Trade Commission. Ms. Moken has represented both plaintiffs and defendants concerning patent infringement, invalidity, and unenforceability, as well as trade secret misappropriation and contract-related matters. Ms. Moken also represents internationally-based clients and she has served as counsel for both domestic and foreign proceedings. Her practice also includes client counseling, due diligence, licensing, trade secrets, unfair competition and opinion work.
Prior to joining Kenyon & Kenyon, during the period of 1993 to 1997, Ms. Moken performed unique research, discovering that disinfectants induce the expression of a gene named mar, conferring multiple antibiotic resistance in bacteria. While at Princeton University, her scientific research focused on metal-assisted assembly of multi-helix protein bundles.
- “Overview of Main IPRs” “United States Main IPRs Q&A,” PLC Cross-border IP in Business Transactions Handbook, 2011 – 2012.
- “Overview of Main IPRs” “United States Main IPRs Q&A,” PLC Cross-border IP in Business Transactions Handbook, 2010 – 2011
- “Appendix to Chapter 12,” Frontiers in Antimicrobial Resistance: a Tribute to Stuart B. Levy, 2005.
- “Federal Circuit Finds an Absence of Utility in DNA Sequences, ESTs: Encumbrance of Patentability Holds Ramifications for Agricultural Industry,” IP Strategist, Oct. 2005.
- “Fallwell.com Transfer Is Answer to Reverend’s Prayers,” World Trademark Law Report, Nov. 9, 2004.
- “Fake Pharmaceuticals: How They and Relevant Legislation or Lack Thereof Contribute to Consistently High and Increasing Drug Prices,” American Journal of Law and Medicine, vol. 29, no. 4, 2003.
- “Selection of Multiple Antibiotic Resistant (mar) Mutants of Escherichia coli by Using the Disinfectant Pine Oil: Roles of mar and acrAB loci,” Antimicrobial Agents of Chemotherapy, Dec. 1997.